Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

150. HIV: Treatment: Friday, 12:15 - 1:30 p.m.

Poster Session: HIV: Treatment

(1582) Dolutegravir/Rilpivirine STR Switch Study in Persons with HIV-1 and Chronic Kidney Disease: 48-week Assessment of Viral Suppression, Treatment Adherence and Quality of Life

Friday, October 13, 2023
12:15 PM – 1:30 PM US ET
Location: Hall B + C

    Presenting Author(s)

  • HK

    Helena Kwakwa, MD, MPH (she/her/hers)

    Director of HIV Clinical Services
    Philadelphia Department of Public Health
    Philadelphia, Pennsylvania, United States

    • Co-Author(s)

  • TS

    Tawanaha Stokes, CRNP

    Nurse Practitioner
    Philadelphia Department of Public Health
    Philadelphia, Pennsylvania, United States

  • MG

    Millen Gebreselassie, MD

    Physician
    Philadelphia Department of Public Health
    Philadelphia, Pennsylvania, United States

  • LM

    Lisa Maslankowski, MD

    HIV Specialist Physician
    Philadelphia Department of Public Health
    Philadelphia, Pennsylvania, United States

  • EC

    Esther Chernak, MD, MPH

    Infectious Disease Physician
    Philadelphia Department of Public Health
    Philadelphia, Pennsylvania, United States